To the Editor.—Recently, iodine-131-metaiodobenzylguanidine, a compound chemically resembling noradrenaline, accumulated in chromaffin tissue as storage granules.1,2 Metaiodobenzylguanidine is an adrenergic neuron blocker, an inhibitor of neuronal uptake, and a presynaptic α2-agonist. The metaiodobenzylguanidine scan is a safe, specific, and noninvasive procedure for the localization of pheochromocytomas3,4; its limit is the possibility of false-negative scans in 10% of patients, whereas computed tomography (CT) visualizes more than 95% of the intra-adrenal tumors.5
Brown and colleagues6 reported a case of a false-positive metaiodobenzylguanidine scan that showed a bilateral adrenal uptake in a patient with a right-sided pheochromocytoma. They concluded that scintigraphy cannot yet replace computed tomography, selected venous sampling, or angiography in the diagnosis of adrenal pheochromocytomas.
Fig 1.—Metaiodobenzylguanidine scan showing area of iodine uptake in the right adrenal gland. MIBEG BKG-SUBTRACT. MIBEG DTPA MIBEG + DTPA
We report the case of a 30-year-old man who presented
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.